Histone deacetylase 7 promotes toll-like receptor 4-dependent proinflammatory gene expression in macrophages

Journal of Biological Chemistry

Volumn 288, Issue 35, 2013, Pages 25362-25374

  Shakespear, Melanie R ^a   Hohenhaus, Daniel M ^a   Kelly, Greg M ^a   Kamal, Nabilah A ^a   Gupta, Praveer ^a   Labzin, Larisa I ^a   Schroder, Kate ^a   Garceau, Valerie ^b   Barbero, Sheila ^a   Iyer, Abishek ^a   Hume, David A ^b   Reid, Robert C ^a   Irvine, Katharine M ^a   Fairlie, David P ^a   Sweet, Matthew J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORY DRUGS; HISTONE DEACETYLASES; INFLAMMATORY MEDIATORS; INFLAMMATORY RESPONSE; ISOFORMS; PROINFLAMMATORY; TOLL-LIKE RECEPTORS;

GENE EXPRESSION;

MACROPHAGES;

HISTONE DEACETYLASE 7; INTERLEUKIN 12P40; INTERLEUKIN 6; THIOGLYCOLIC ACID; TOLL LIKE RECEPTOR 4;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; BONE MARROW CELL; CONTROLLED STUDY; EDN1 GENE; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE INTERACTION; GENE OVEREXPRESSION; HDAC7 S GENE; HDAC7 U GENE; HYPOXIA; IL 12P40 GENE; IL 6 GENE; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RADIOIMMUNOPRECIPITATION; UPREGULATION;

HISTONE DEACETYLASE; HYPOXIA-INDUCIBLE FACTOR (HIF); INFLAMMATION; MACROPHAGES; TOLL-LIKE RECEPTOR (TLR);

ALCOHOL OXIDOREDUCTASES; ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEK293 CELLS; HISTONE DEACETYLASES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84883336983     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.496281     Document Type: Article

References (59)

1. Kawai, T., and Akira, S. (2010) The role of pattern-recognition receptors in innate immunity. Update on Toll-like receptors. Nat. Immunol. 11, 373-384
2. Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., Lacy-Hulbert, A., El Khoury, J., Golenbock, D. T., and Moore, K. J. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155-161
3. Kim, S., Takahashi, H., Lin, W. W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J. L., and Karin, M. (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106
4. Park, J. S., Svetkauskaite, D., He, Q., Kim, J. Y., Strassheim, D., Ishizaka, A., and Abraham, E. (2004) Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370-7377
5. Huang, Q., and Pope, R. M. (2010) Toll-like receptor signaling. A potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis. J. Leukoc Biol. 88, 253-262
6. Hennessy, E. J., Parker, A. E., and O'Neill, L. A. (2010) Targeting Toll-like receptors. Emerging therapeutics Nat. Rev. Drug Discov. 9, 293-307
7. O'Neill, L. A., Bryant, C. E., and Doyle, S. L. (2009) Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol. Rev. 61, 177-197
8. Jenkins, K. A., and Mansell, A. (2010) TIR-containing adaptors in Toll-like receptor signalling. Cytokine 49, 237-244
9. Carpenter, S., and O'Neill, L. A. (2009) Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem. J. 422, 1-10
10. Cao, W., Bao, C., Padalko, E., and Lowenstein, C. J. (2008) Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J. Exp. Med. 205, 1491-1503
11. Tang, X., Gao, J. S., Guan, Y. J., McLane, K. E., Yuan, Z. L., Ramratnam, B., and Chin, Y. E. (2007) Acetylation-dependent signal transduction for type I interferon receptor. Cell 131, 93-105
12. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., and Mann, M. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840
13. Marks, P. A. (2010) The clinical development of histone deacetylase inhibitors as targeted anticancer drugs. Expert Opin. Investig. Drugs 19, 1049-1066
14. Halili, M. A., Andrews, M. R., Sweet, M. J., and Fairlie, D. P. (2009) Histone deacetylase inhibitors in inflammatory disease. Curr. Top. Med. Chem. 9, 309-319
15. Tao, R., de Zoeten, E. F., Ozkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B., Turka, L. A., Olson, E. N., Greene, M. I., Wells, A. D., and Hancock, W. W. (2007) Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299-1307
16. Bosisio, D., Vulcano, M., Del Prete, A., Sironi, M., Salvi, V., Salogni, L., Riboldi, E., Leoni, F., Dinarello, C. A., Girolomoni, G., and Sozzani, S. (2008) Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo. J. Leukoc Biol. 84, 1540-1548
17. Aung, H. T., Schroder, K., Himes, S. R., Brion, K., van Zuylen, W., Trieu, A., Suzuki, H., Hayashizaki, Y., Hume, D. A., Sweet, M. J., and Ravasi, T. (2006) LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB J. 20, 1315-1327
18. Halili, M. A., Andrews, M. R., Labzin, L. I., Schroder, K., Matthias, G., Cao, C., Lovelace, E., Reid, R. C., Le, G. T., Hume, D. A., Irvine, K. M., Matthias, P., Fairlie, D. P., and Sweet, M. J. (2010) Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. J. Leukoc. Biol. 87, 1103-1114
19. Leoni, F., Zaliani, A., Bertolini, G., Porro, G., Pagani, P., Pozzi, P., Donà, G., Fossati, G., Sozzani, S., Azam, T., Bufler, P., Fantuzzi, G., Goncharov, I., Kim, S. H., Pomerantz, B. J., Reznikov, L. L., Siegmund, B., Dinarello, C. A., and Mascagni, P. (2002) The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc. Natl. Acad. Sci. U.S.A. 99, 2995-3000
20. Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X. C., Chanson, A. L., Reymond, M. K., Miconnet, I., Schrenzel, J., François, P., and Calandra, T. (2011) Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 117, 1205-1217
21. Nencioni, A., Beck, J., Werth, D., Grünebach, F., Patrone, F., Ballestrero, A., and Brossart, P. (2007) Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. Clin. Cancer Res. 13, 3933-3941
22. Bode, K. A., Schroder, K., Hume, D. A., Ravasi, T., Heeg, K., Sweet, M. J., and Dalpke, A. H. (2007) Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment. Immunology 122, 596-606
23. Brogdon, J. L., Xu, Y., Szabo, S. J., An, S., Buxton, F., Cohen, D., and Huang, Q. (2007) Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function. Blood 109, 1123-1130
24. Shakespear, M. R., Halili, M. A., Irvine, K. M., Fairlie, D. P., and Sweet, M. J. (2011) Histone deacetylases as regulators of inflammation and immunity. Trends Immunol. 32, 335-343
25. Guardiola, A. R., and Yao, T. P. (2002) Molecular cloning and characterization of a novel histone deacetylase HDAC10. J. Biol. Chem. 277, 3350-3356
26. Martin, M., Kettmann, R., and Dequiedt, F. (2007) Class IIa histone deacetylases. Regulating the regulators. Oncogene 26, 5450-5467
27. Stacey, K. J., Young, G. R., Clark, F., Sester, D. P., Roberts, T. L., Naik, S., Sweet, M. J., and Hume, D. A. (2003) The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J. Immunol. 170, 3614-3620
28. Tessier, P., Smil, D. V., Wahhab, A., Leit, S., Rahil, J., Li, Z., Déziel, R., and Besterman, J. M. (2009) Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors. Bioorg. Med. Chem. Lett. 19, 5684-5688
29. Needham, L. A., Davidson, A. H., Bawden, L. J., Belfield, A., Bone, E. A., Brotherton, D. H., Bryant, S., Charlton, M. H., Clark, V. L., Davies, S. J., Donald, A., Day, F. A., Krige, D., Legris, V., McDermott, J., McGovern, Y., Owen, J., Patel, S. R., Pintat, S., Testar, R. J., Wells, G. M., Moffat, D., and Drummond, A. H. (2011) Drug targeting to monocytes and macrophages using esterase-sensitive chemical motifs. J. Pharmacol. Exp. Ther. 339, 132-142
30. Ripoll, V. M., Irvine, K. M., Ravasi, T., Sweet, M. J., and Hume, D. A. (2007) Gpnmb is induced in macrophages by IFN-γ and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. J. Immunol. 178, 6557-6566
31. Margariti, A., Xiao, Q., Zampetaki, A., Zhang, Z., Li, H., Martin, D., Hu, Y., Zeng, L., and Xu, Q. (2009) Splicing of HDAC7 modulates the SRF-myocardin complex during stem-cell differentiation towards smooth muscle cells. J. Cell Sci. 122, 460-470
32. Dhaun, N., Webb, D. J., and Kluth, D. C. (2012) Endothelin-1 and the kidney. Beyond BP. Br. J. Pharmacol. 167, 720-731
33. Paulus, P., Jennewein, C., and Zacharowski, K. (2011) Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis Biomarkers 16, S11-21
34. Iglarz, M., and Clozel, M. (2010) At the heart of tissue: endothelin system and end-organ damage. Clin. Sci. 119, 453-463
35. Peyssonnaux, C., Cejudo-Martin, P., Doedens, A., Zinkernagel, A. S., Johnson, R. S., and Nizet, V. (2007) Cutting edge. Essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J. Immunol. 178, 7516-7519
36. Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., Zheng, L., Gardet, A., Tong, Z., Jany, S. S., Corr, S. C., Haneklaus, M., Caffrey, B. E., Pierce, K., Walmsley, S., Beasley, F. C., Cummins, E., Nizet, V., Whyte, M., Taylor, C. T., Lin, H., Masters, S. L., Gottlieb, E., Kelly, V. P., Clish, C., Auron, P. E., Xavier, R. J., and O'Neill, L. A. (2013) Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238-242
37. Yamashita, K., Discher, D. J., Hu, J., Bishopric, N. H., and Webster, K. A. (2001) Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP. J. Biol. Chem. 276, 12645-12653
38. Kato, H., Tamamizu-Kato, S., and Shibasaki, F. (2004) Histone deacetylase 7 associates with hypoxia-inducible factor 1α and increases transcriptional activity. J. Biol. Chem. 279, 41966-41974
39. Dressel, U., Bailey, P. J., Wang, S. C., Downes, M., Evans, R. M., and Muscat, G. E. (2001) A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J. Biol. Chem. 276, 17007-17013
40. Zhang, C. L., McKinsey, T. A., Lu, J. R., and Olson, E. N. (2001) Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J. Biol. Chem. 276, 35-39
41. Song, W., Tai, Y. T., Tian, Z., Hideshima, T., Chauhan, D., Nanjappa, P., Exley, M. A., Anderson, K. C., and Munshi, N. C. (2011) HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells. Leukemia 25, 161-168
42. Leoni, F., Fossati, G., Lewis, E. C., Lee, J. K., Porro, G., Pagani, P., Modena, D., Moras, M. L., Pozzi, P., Reznikov, L. L., Siegmund, B., Fantuzzi, G., Dinarello, C. A., and Mascagni, P. (2005) The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol. Med. 11, 1-15
43. Fischle, W., Dequiedt, F., Fillion, M., Hendzel, M. J., Voelter, W., and Verdin, E. (2001) Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. J. Biol. Chem. 276, 35826-35835
44. Chen, X., Barozzi, I., Termanini, A., Prosperini, E., Recchiuti, A., Dalli, J., Mietton, F., Matteoli, G., Hiebert, S., and Natoli, G. (2012) Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc. Natl. Acad. Sci. U.S.A. 109, E2865-2874
45. Mullican, S. E., Gaddis, C. A., Alenghat, T., Nair, M. G., Giacomin, P. R., Everett, L. J., Feng, D., Steger, D. J., Schug, J., Artis, D., and Lazar, M. A. (2011) Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev. 25, 2480-2488
46. Nizet, V., and Johnson, R. S. (2009) Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9, 609-617
47. Blouin, C. C., Pagé, E. L., Soucy, G. M., and Richard, D. E. (2004) Hypoxic gene activation by lipopolysaccharide in macrophages. Implication of hypoxia- inducible factor 1α. Blood 103, 1124-1130
48. Frede, S., Stockmann, C., Freitag, P., and Fandrey, J. (2006) Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB. Biochem. J. 396, 517-527
49. Kim, S. H., Jeong, J. W., Park, J. A., Lee, J. W., Seo, J. H., Jung, B. K., Bae, M. K., and Kim, K. W. (2007) Regulation of the HIF-1α stability by histone deacetylases. Oncol. Rep 17, 647-651
50. Qian, D. Z., Kachhap, S. K., Collis, S. J., Verheul, H. M., Carducci, M. A., Atadja, P., and Pili, R. (2006) Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α. Cancer Res. 66, 8814-8821
51. Parra, M., Kasler, H., McKinsey, T. A., Olson, E. N., and Verdin, E. (2005) Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. J. Biol. Chem. 280, 13762-13770
52. Aude-Garcia, C., Collin-Faure, V., Bausinger, H., Hanau, D., Rabilloud, T., and Lemercier, C. (2010) Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression. Biochem. J. 430, 237-244
53. de Zoeten, E. F., Wang, L., Sai, H., Dillmann, W. H., and Hancock, W. W. (2010) Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology 138, 583-594
54. Villagra, A., Cheng, F., Wang, H. W., Suarez, I., Glozak, M., Maurin, M., Nguyen, D., Wright, K. L., Atadja, P. W., Bhalla, K., Pinilla-Ibarz, J., Seto, E., and Sotomayor, E. M. (2009) The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat. Immunol. 10, 92-100
55. Hemmatazad, H., Rodrigues, H. M., Maurer, B., Brentano, F., Pileckyte, M., Distler, J. H., Gay, R. E., Michel, B. A., Gay, S., Huber, L. C., Distler, O., and Jüngel, A. (2009) Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. Arthritis Rheum. 60, 1519-1529
56. Higashi-Kuwata, N., Jinnin, M., Makino, T., Fukushima, S., Inoue, Y., Muchemwa, F. C., Yonemura, Y., Komohara, Y., Takeya, M., Mitsuya, H., and Ihn, H. (2010) Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res. Ther 12, R128
57. Lagares, D., García-Fernández, R. A., Jiménez, C. L., Magán-Marchal, N., Busnadiego, O., Lamas, S., and Rodríguez-Pascual, F. (2010) Endothelin 1 contributes to the effect of transforming growth factor Rβ1 on wound repair and skin fibrosis. Arthritis Rheum. 62, 878-889
58. Higashiyama, R., Miyaki, S., Yamashita, S., Yoshitaka, T., Lindman, G., Ito, Y., Sasho, T., Takahashi, K., Lotz, M., and Asahara, H. (2010) Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. Mod. Rheumatol. 20, 11-17
59. Barneda-Zahonero, B., Román-González, L., Collazo, O., Rafati, H., Islam, A. B., Bussmann, L. H., di Tullio, A., De Andres, L., Graf, T., López-Bigas, N., Mahmoudi, T., and Parra, M. (2013) HDAC7 is a repressor of myeloid genes whose down-regulation is required for transdifferentiation of pre-B cells into macrophages. PLoS Genet. 9, e1003503